Chloroquine inhibits production of TNF-α, IL-1β and IL-6 from lipopolysaccharide-stimulated human monocytes/macrophages by different modes

被引:249
作者
Jang, C. -H. [1 ]
Choi, J. -H. [1 ]
Byun, M. -S. [1 ]
Jue, D. -M. [1 ]
机构
[1] Catholic Univ Korea, Coll Med, Dept Biochem, Seoul 137701, South Korea
关键词
chloroquine; rheumatoid arthritis; cytokines; gene regulation; monocytes/macrophages; inflammation;
D O I
10.1093/rheumatology/kei282
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives. TNF-alpha, IL-1 and IL-6 are known to have primary roles in the pathogenesis of rheumatoid arthritis and other inflammatory diseases. The anti-rheumatic drug chloroquine has been shown to inhibit TNF-alpha, IL-1 and IL-6 production from mononuclear phagocytes. We examined the underlying mechanisms involved in the chloroquine-induced inhibition of cytokine production. Methods. Human peripheral blood mononuclear cells and monocytes/macrophages and monocytic U-937 and THP-1 cells were stimulated with lipopolysaccharide, and TNF-alpha, IL-1 beta and IL-6 production was measured by ELISA. Levels of mRNA were measured by northern blotting and reverse transcription-polymerase chain reaction. Synthesis of 26-kDa TNF-alpha precursor was measured by metabolic labelling and immunoprecipitation analysis. Transcription rate was determined by nuclear run-on assay. Results. TNF-alpha release from the cells was inhibited by chloroquine, whereas the steady-state level of TNF-alpha mRNA and synthesis of 26-kDa TNF-alpha precursor were not changed by chloroquine. In contrast, chloroquine-induced inhibition of IL-1 beta and IL-6 release was accompanied by a decrease in their steady-state mRNA levels. The transcription rates of the IL-1 beta and IL-6 genes were not changed by chloroquine, whereas the stability of IL-1 beta and IL-6 mRNA was decreased by chloroquine. Weak-base amines such as methylamine and ammonium chloride had no effect on the production of TNF-alpha, whereas they partially blocked the production of IL-1 beta and IL-6. Conclusions. Our results indicate that chloroquine-mediated inhibition of TNF-alpha, IL-1 beta and IL-6 synthesis occurs through different modes in lipopolysaccharide-stimulated human monocytes/macrophages: it blocks the conversion of cell-associated TNF-alpha precursor to mature soluble protein, whereas it reduces the levels of IL-1 beta and IL-6 mRNA, at least in part, by decreasing their stability and by a pH-dependent mechanism.
引用
收藏
页码:703 / 710
页数:8
相关论文
共 45 条
[1]   INTERLEUKIN-6 IN BIOLOGY AND MEDICINE [J].
AKIRA, S ;
TAGA, T ;
KISHIMOTO, T .
ADVANCES IN IMMUNOLOGY, VOL 54, 1993, 54 :1-78
[2]   A murine transmembrane tumor necrosis factor (TNF) transgene induces arthritis by cooperative p55/p75 TNF receptor signaling [J].
Alexopoulou, L ;
Pasparakis, M ;
Kollias, G .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1997, 27 (10) :2588-2592
[3]   The secretory route of the leaderless protein interleukin 1β involves exocytosis of endolysosome-related vesicles [J].
Andrei, C ;
Dazzi, C ;
Lotti, L ;
Torrisi, MR ;
Chimini, G ;
Rubartelli, A .
MOLECULAR BIOLOGY OF THE CELL, 1999, 10 (05) :1463-1475
[4]   INHIBITION OF THE PRODUCTION AND EFFECTS OF INTERLEUKIN-1 AND TUMOR-NECROSIS-FACTOR-ALPHA IN RHEUMATOID-ARTHRITIS [J].
AREND, WP ;
DAYER, JM .
ARTHRITIS AND RHEUMATISM, 1995, 38 (02) :151-160
[5]  
Bresnihan B, 1998, ARTHRITIS RHEUM, V41, P2196, DOI 10.1002/1529-0131(199812)41:12<2196::AID-ART15>3.0.CO
[6]  
2-2
[7]   Therapeutic benefit of blocking interleukin-6 activity with an anti-interleukin-6 receptor monoclonal antibody in rheumatoid arthritis - A randomized, double-blind, placebo-controlled, dose-escalation trial [J].
Choy, EHS ;
Isenberg, DA ;
Garrood, T ;
Farrow, S ;
Ioannou, Y ;
Bird, H ;
Cheung, N ;
Williams, B ;
Hazleman, B ;
Price, R ;
Yoshizaki, K ;
Nishimoto, N ;
Kishimoto, T ;
Panayi, GS .
ARTHRITIS AND RHEUMATISM, 2002, 46 (12) :3143-3150
[8]   Mechanisms of disease: Cytokine pathways and joint inflammation in rheumatoid arthritis. [J].
Choy, EHS ;
Panayi, GS .
NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (12) :907-916
[9]  
DECKER T, 1987, J IMMUNOL, V138, P957
[10]  
Dokter WHA, 1996, LEUKEMIA, V10, P1308